Letter: Adherence and Persistence on Relugolix for the Treatment of Prostate Cancer in the United States Medicare Fee-for-Service Population Letter

publication date

  • May 1, 2026

webpage

published in

start page

  • 228

end page

  • 229

volume

  • 13

issue

  • 3